LYRA THERAPEUTICS INC

CUSIP: 55234L105 Class: Common Stock

Samsara BioCapital, LLC's Holding History (CIK: 0001744967)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 1,390,130 Value ($000) $176 Avg Close Range
Q4 2024
Shares 1,965,689 Value ($000) $406 Avg Close Range
Q3 2024
Shares 2,780,261 Value ($000) $715 Avg Close Range
Q2 2024
Shares 2,780,261 Value ($000) $769 Avg Close Range
Q1 2024
Shares 2,780,261 Value ($000) $17,293 Avg Close Range
Q4 2023
Shares 2,780,261 Value ($000) $14,569 Avg Close Range
Q3 2023
Shares 2,780,261 Value ($000) $10,871 Avg Close Range
Q2 2023
Shares 2,780,261 Value ($000) $11,427 Avg Close Range
Q1 2023
Shares 1,777,251 Value ($000) $3,572 Avg Close Range
Q4 2022
Shares 1,777,251 Value ($000) $5,581 Avg Close Range
Q3 2022
Shares 1,777,251 Value ($000) $8,904 Avg Close Range
Q2 2022
Shares 1,777,251 Value ($000) $10,041 Avg Close Range